New pill aims to shrink bladder tumors before surgery
NCT ID NCT03914794
Summary
This study tested if taking a targeted pill called pemigatinib for 4-6 weeks could shrink or eliminate recurrent, non-invasive bladder tumors before standard surgery. It involved 30 patients with a history of low- or intermediate-risk tumors that had come back. The main goal was to see if the drug led to a complete disappearance of the tumor by the time of surgery.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLADDER CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Associated Medical Professionals Urology
Syracuse, New York, 13210, United States
-
Carolina Urologic Research Center
Myrtle Beach, South Carolina, 29572, United States
-
Johns Hopkins School of Medicine - Sidney Kimmel Comprehensive Cancer Center
Baltimore, Maryland, 21205, United States
-
Keystone Urology
Lancaster, Pennsylvania, 17604, United States
-
Midlantic Urology
Bala-Cynwyd, Pennsylvania, 19004, United States
-
Sibley Memorial Hospital
Washington D.C., District of Columbia, 20016, United States
Conditions
Explore the condition pages connected to this study.